Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 35, Issue 10, 2011, Pages 1345-1349

  Takeuchi, Seisho ^a   Matsushita, Masahide ^a   Zimmermann, Martin ^b   Ikezoe, Takayuki ^a   Komatsu, Naoki ^a   Seriu, Taku ^c   Schrappe, Martin ^d   Bartram, Claus R ^c   Koeffler, H Phillip ^e,f  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

ALL; Methylation; Multiple genes

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE DISTRIBUTION; APC GENE; ARTICLE; B CELL LEUKEMIA; CANCER CLASSIFICATION; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CYCLIN D2 GENE; DAPK GENE; DNA DETERMINATION; DNA METHYLATION; FEMALE; FHIT GENE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; LEUKEMIA RELAPSE; MALE; MGMT GENE; MLH1 GENE; P14 GENE; P15 GENE; P21 GENE; P27 GENE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RAR BETA GENE; RB GENE; SCHOOL CHILD; SHP1 GENE; T CELL LEUKEMIA; TUMOR GENE;

ADOLESCENT; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CASE-CONTROL STUDIES; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; DNA, NEOPLASM; FEMALE; GENES, P16; HUMANS; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROMOTER REGIONS, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 80052077665     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.04.015     Document Type: Article

References (21)

1. Pui C.-H., Robison L.L., Look A.T. Acute lymphoblastic leukemia. Lancet 2008, 371:1030-1043.
2. Uehara E., Takeuchi S., Tasaka T., Matsuhashi Y., Yang Y., Fujita M., et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia. Int J Oncol 2003, 23:693-696.
3. Kuang S.Q., Tong W.G., Yang H., Lin W., Lee M.K., Fang Z.H., et al. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia 2008, 22:1529-1538.
4. Taylor K.H., Pena-Hernandez K.E., Davis J.W., Arthur G.L., Duff D.J., Shi H., et al. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res 2007, 67:2617-2625.
5. Garcia-Manero G., Daniel J., Smith T.L., Kornblau S.M., Lee M.-S., Kantarjian H.M., et al. DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia. Clin Cancer Res 2002, 8:2217-2224.
6. Garcia-Manero G., Jeha S., Daniel J., Williamson J., Albitar M., Kantarjian H.M., et al. Aberrant DNA methylation in pediatric patients with acute lymphoblastic leukemia. Cancer 2003, 97:695-702.
7. Gutierrez M.I., Siraj A.K., Bhargava M., Ozbek U., Banavali S., Chaudhary M.A., et al. Concurrent methylation of multiple genes in childhood ALL: correlation with phenotype and molecular subgroup. Leukemia 2003, 17:1845-1850.
8. Stanulla M., Schaeffeler E., Flohr T., Cario G., Schrauder A., Zimmermann M., et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005, 293:1485-1489.
9. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B., Methylation-specific P.C.R. a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93:9821-9826.
10. Roman-Gomez J., Jimenez-Velasco A., Castillejo J.A., Agirre X., Barrios M., Navarro G., et al. Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. Blood 2004, 104:2492-2498.
11. Yang Y., Takeuchi S., Hofmann W.K., Ikezoe T., van Dongen J.J., Szczepański T., et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in acute lymphoblastic leukemia. Leukemia Res 2006, 30:98-102.
12. Zheng S., Ma X., Zhang L., Gunn L., Smith M.T., Wiemels J.L., et al. Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res 2004, 64:2000-2006.
13. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Navarro G., Calasanz M.J., et al. CpG island methylator phenotype redefines the prognostic effect of t[12;21] in childhood acute lymphoblastic leukemia. Clin Cancer Res 2006, 12:4845-4850.
14. Jones L.C., Tefferi A., Idos G.E., Kumagai T., Hofmann W.K., Koeffler H.P. RARβ2 is a candidate tumor suppressor gene in myelofibrosis with myeloid metaplasia. Oncogene 2004, 23:7846-7853.
15. Chim C.S., Wong S.Y., Kwong Y.L. Aberant gene promoter methylation in acute promyelocytic leukaemia: profile and prognostic significance. Br J Haematol 2003, 122:571-578.
16. Croce L.D., Raker V.A., Corsaro M., Fazi F., Fanelli M., Faretta M., et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002, 295:1079-1082.
17. Tsellou E., Troungos C., Moschovi M., Athanasiadou-Piperopoulou F., Polychronopoulou S., Kosmidis H., et al. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia. Eur J Cancer 2005, 41:584-589.
18. Mirebeau D., Acquaviva C., Suciu S., Bertin R., Dastugue N., Robert A., et al. EORTC-CLG: The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951. Haematologica 2006, 91:881-885.
19. Milani L., Lundmark A., Kiialainen A., Nordlund J., Flaegstad T., Forestier E., et al. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood 2010, 115:1214-1225.
20. Roman-Gomez J., Jimenez-Velasco A., Agirre X., Castillejo J.A., Navarro G., Garate L., et al. Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome. Leukemia 2006, 20:1445-1448.
21. Matsushita C., Yang Y., Takeuchi S., Matsushita M., van Dongen J.J.M., Szczepański T., et al. Aberrant methylation in promoter-associated CpG islands of multiple genes in relapsed childhood acute lymphoblastic leukemia. Oncol Rep 2004, 12:97-99.